Trials / Not Yet Recruiting
Not Yet RecruitingNCT06225609
No Stoma VS Ghost Stoma in Patients Undergoing Total Mesorectal Excision for Rectal Cancer
Ghost Ileostomy Group Versus no Stoma Group in Patients Undergoing Total Mesorectal Excision for Rectal Cancer: A Randomized Controlled Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- fan li · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the number of hospitalizations with ghost ileostomy group versus no ileostomy group after total mesorectal excision for rectal cancer.
Detailed description
So far, there are no relevant reports on ghost ileostomy among the Asian population, and all studies are small sample studies.In the past decades, with the advent of circular stapling devices, many middle and low rectal cancers have chosen new sphincter-saving procedures (such as ISR and Ta TME). Nevertheless, when the incidence rate of AL remains high, is diverting ileostomy applicable? Is ghost ileostomy applicable to rectal cancer in the context of new surgical procedures such as pelvic floor reconstruction, perineal drainage, anastomotic reinforcement and robotic surgery? Is this delayed stoma safe and feasible with the increase of preoperative neoadjuvant therapy? Therefore, our study proposes to summarize the review of the complications of GI and no stoma to explore the safety and effectiveness of GI in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ghost ileostomy | Laparoscopic or robotic surgery with ghost ileostomy |
| PROCEDURE | No ileostomy | Laparoscopic or robotic surgery with no ileostomy |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2025-03-01
- Completion
- 2027-03-01
- First posted
- 2024-01-26
- Last updated
- 2024-01-26
Source: ClinicalTrials.gov record NCT06225609. Inclusion in this directory is not an endorsement.